These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24952714)

  • 1. Infliximab therapy for Crohn's-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report.
    Akazawa Y; Takeshima F; Yajima H; Imanishi D; Kanda T; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Hayashi T; Nakashima M; Nakao K
    BMC Res Notes; 2014 Jun; 7():382. PubMed ID: 24952714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus complicated by Crohn's disease: a case report and literature review.
    Yamashita H; Ueda Y; Kawaguchi H; Suzuki A; Takahashi Y; Kaneko H; Kano T; Mimori A
    BMC Gastroenterol; 2012 Dec; 12():174. PubMed ID: 23216789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of Crohn's disease successfully treated with infliximab without steroid].
    Fujise T; Iwakiri R; Tsunada S; Morita H; Kikkawa A; Ootani A; Sakata H; Fujimoto K
    Nihon Shokakibyo Gakkai Zasshi; 2006 Mar; 103(3):295-300. PubMed ID: 16688960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab.
    Ashizuka S; Kuroishi N; Nakashima K; Inatsu H; Kita T; Kitamura K
    Intern Med; 2019 Jun; 58(11):1573-1576. PubMed ID: 30713309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflixmab as a possible treatment for the hemorrhagic type of Crohn's disease.
    Tsujikawa T; Nezu R; Andoh A; Saotome T; Araki Y; Ishizuka Y; Sasaki M; Koyama S; Fujiyama Y
    J Gastroenterol; 2004; 39(3):284-7. PubMed ID: 15065007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada.
    Panaccione R;
    Can J Gastroenterol; 2001 Jun; 15(6):371-5. PubMed ID: 11429666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for severe recurrent Crohn's disease presenting with massive gastrointestinal hemorrhage.
    Papi C; Gili L; Tarquini M; Antonelli G; Capurso L
    J Clin Gastroenterol; 2003 Mar; 36(3):238-41. PubMed ID: 12590236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab stopped severe gastrointestinal bleeding in Crohn's disease.
    Aniwan S; Eakpongpaisit S; Imraporn B; Amornsawadwatana S; Rerknimitr R
    World J Gastroenterol; 2012 Jun; 18(21):2730-4. PubMed ID: 22690085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
    Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in treatment of Crohn's disease: the Milan experience.
    Ardizzone S; Colombo E; Maconi G; Bollani S; Manzionna G; Petrone MC; Bianchi Porro G
    Dig Liver Dis; 2002 Jun; 34(6):411-8. PubMed ID: 12132788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication].
    Lee KM; Kim JS; Shin DH; Cheong JY; Yoo BM; Kim JK; Lee KJ; Hahm KB; Kim JH; Cho SW
    Korean J Gastroenterol; 2004 Nov; 44(5):259-66. PubMed ID: 15564805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infliximab treatment of severe bleeding complicating Crohn's disease].
    Julián Gómez L; Atienza R; Barrio J; Gil P; Gómez de la Cuesta S; Pinto P; Alcaide N; Caro Patón A
    Rev Esp Enferm Dig; 2010 Jan; 102(1):57-8. PubMed ID: 20187687
    [No Abstract]   [Full Text] [Related]  

  • 15. [X-linked inhibitor of apoptosis deficiency manifested as Crohn's disease: a case report and literature review].
    Xu LJ; Luo YY; Yu JD; Lou JG; Fang YH; Chen J
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):43-47. PubMed ID: 29342997
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab for severe gastrointestinal bleeding in Crohn's disease.
    Ando Y; Matsushita M; Kawamata S; Shimatani M; Fujii T; Okazaki K
    Inflamm Bowel Dis; 2009 Mar; 15(3):483-4. PubMed ID: 18668673
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial.
    Strik AS; van de Vrie W; Bloemsaat-Minekus JPJ; Nurmohamed M; Bossuyt PJJ; Bodelier A; Rispens T; van Megen YJB; D'Haens GR;
    Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):404-412. PubMed ID: 29606564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of refractory pediatric Crohn's disease with a successful treatment by infliximab therapy].
    Park SH; Jeen YT; Chun HR; Kim DI; Baeck CW; Kim YS; Chun HJ; Lee HS; Um SH; Choi JH; Kim CD; Ryu HS; Hyun JH
    Korean J Gastroenterol; 2005 Oct; 46(4):297-301. PubMed ID: 16247274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF-α treatment for post-anastomotic ulcers and inflammatory bowel disease with Crohn's-like pathologic changes following intestinal surgery in pediatric patients.
    Freeman JJ; Rabah R; Hirschl RB; Maspons A; Meier D; Teitelbaum DH
    Pediatr Surg Int; 2015 Jan; 31(1):77-82. PubMed ID: 25348881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.